Paul R. Sanberg
Ph.D., D.Sc. - Co-Founder
Saneron CCEL Therapeutics, Inc.
United States of America
Dr. Sanberg is a co-inventor on all of Saneron's licensed technology. He has extensive experience in bringing neural transplantation therapies from the laboratory to the clinic. The companies are involved in cell therapy for degenerative disorders. He has also been on the Board of Directors for Medical Advisory Systems, Inc. (AMEX: DOC), and on numerous Scientific Advisory Boards for Companies and Foundations. His industry experience has included being Scientific Director for CytoTherapeutics, Inc., (Providence, Rhode Island), now Stem Cells, Inc., (Palo Alto, California) and was CSO and on the Board of Directors for Layton BioScience, Inc. (Atherton, California). Most recently, he co-founded, Nutritherapeutics, Inc. in order to develop natural products to promote healing. Dr. Paul R. Sanberg is Distinguished University Professor and Director of the Center of Excellence for Aging and Brain Repair and Associate Vice President/Associate Dean for Biotechnology Development at the University Of South Florida College Of Medicine. He trained at York University, the University of British Columbia, the Australian National University and at the Johns Hopkins University School of Medicine. Dr. Sanberg has held academic positions at the Ohio University, the University of Cincinnati, and Brown University prior to his current position. Dr. Sanberg is Editor-in-Chief of Cell Transplantation, Executive Director of the American Society for Neural Transplantation and Repair, and past president of the Cell Transplant Society, and others. He is the author of more than 400 scientific articles including thirteen books and is an inventor on over twenty U.S. patents. His early work was pioneering in understanding the role of cell death in neurological disorders.
His intrested in Neural Transplantation researches.